医学
去骨瓣减压术
改良兰金量表
蛛网膜下腔出血
颅内压
中线偏移
格拉斯哥昏迷指数
室外引流
单变量分析
外科
危险系数
麻醉
创伤性脑损伤
脑积水
内科学
缺血
多元分析
计算机断层摄影术
置信区间
缺血性中风
精神科
作者
Yonghong Duan,Jian He,Xiaofei Liu,Yuanding Jiang,Tao Wang,Jie Luo,Peng Xu,Yong-Dong Li,Zhen-Kun Xiao,Aihua Liu,Fei Peng,Yongmei Yang
标识
DOI:10.1016/j.wneu.2022.06.147
摘要
The Subarachnoid Hemorrhage Early Brain Edema Score (SEBES) is a radiographic marker for early brain injury after aneurysmal subarachnoid hemorrhage (aSAH). We evaluated the role of the SEBES in performing decompressive craniectomy (DC) for poor-grade aSAH. We retrospectively analyzed all cases of poor-grade (World Federation of Neurosurgical Societies [WFNS] grade IV and V) aSAH in adults who underwent microsurgery at our center between April 2017 and March 2021. Patient demographics, clinical presentation, imaging findings, and surgical data were obtained. The study endpoints of DC rate, complications, and functional outcomes (modified Rankin Scale score >3) were compared between the traditional surgery and SEBES-informed groups. A survival analysis was performed to estimate 180-day survival and hazard ratios for death. The study included 116 patients (mean age, 60.8 ± 9.5 years, DCs [n = 63, 54.3%]). In the univariate analysis, age, intracranial pressure, midline shift, pupil changes, SEBES grade III–IV, traditional group, and WFNS grade Ⅴ were associated with DC. DC (46.4% vs. 67.4%) and in-hospital mortality rates (9.6% vs. 25.6%) were significantly lower in the SEBES-informed group. At day 180 after admission, modified Rankin Scale scores did not significantly differ between the 2 groups, but 180-day survival was significantly higher in the SEBES-informed group (78.1% vs. 53.5%). In the multivariable analysis, age, pupil changes, being in the traditional group, and delayed cerebral ischemia were independently associated with 180-day postadmission mortality. The SEBES provides good imaging support for preoperative and intraoperative intracranial pressure management in poor-grade aSAH, allowing for improved DC-related decision-making and better 180-day survival.
科研通智能强力驱动
Strongly Powered by AbleSci AI